|
1
|
Dai J, Shen J, Pan W, Shen S and Das UN:
Effects of polyunsaturated fatty acid on the growth of gastric
cancer cells in vitro. Lipids Health Dis. 12:712013.
|
|
2
|
Rasul A, Khan M, Yu B, Ma T and Yang H:
Xanthoxyletin, a coumarin induces S phase arrest and apoptosis in
human gastric adenocarcinoma SGC-7901 cells. Asian Pac J Cancer
Prev. 12:1219–1223. 2011.
|
|
3
|
Zhang C, Xu W, Pan W, et al:
Selenium-binding protein 1 may decrease gastric cellular
proliferation and migration. Int J Oncol. 42:1620–1629. 2013.
|
|
4
|
Ferlay J, Shi HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917
|
|
5
|
Evan GI and Vousden KH: Proliferation,
cell cycle and apoptosis in cancer. Nature. 411:342–348. 2001.
|
|
6
|
Jin CY, Choi YH, Moon DO, et al: Induction
of G2/M arrest and apoptosis in human gastric epithelial AGS cells
by aqueous extract of Agaricus blazei. Oncol Rep.
16:1349–1355. 2006.
|
|
7
|
Wang X, Zhu S, Drozda M, et al:
Minocycline inhibits caspase-independent and -dependent
mitochondrial cell death pathways in models of Huntington’s
disease. Proc Natl Acad Sci USA. 100:10483–10487. 2003.
|
|
8
|
Huang WW, Ko SW, Tasi HY, et al:
Cantharidin induces G2/M phase arrest and apoptosis in human
colorectal cancer colo 205 cells through inhibition of CDK1
activity and caspase-dependent signaling pathways. Int J Oncol.
38:1067–1073. 2011.
|
|
9
|
Rauh R, Kahl S, Boechzelt H, Bauer R,
Kaina B and Efferth T: Molecular biology of cantharidin in cancer
cells. Chin Med. 2:82007.
|
|
10
|
Dorn DC, Kou CA, Png KJ and Moore MA: The
effect of cantharidins on leukemic stem cells. Int J Cancer.
124:2186–2199. 2009.
|
|
11
|
Moed L, Shwayder TA and Chang MW:
Cantharidin revisited: a blistering defense of an ancient medicine.
Arch Dermatol. 137:1357–1360. 2001.
|
|
12
|
Li W, Xie L, Chen Z, et al: Cantharidin, a
potent and selective PP2A inhibitor, induces an oxidative
stress-independent growth inhibition of pancreatic cancer cells
through G2/M cell-cycle arrest and apoptosis. Cancer Sci.
101:1226–1233. 2010.
|
|
13
|
Kuo JH, Chu YL, Yang JS, et al:
Cantharidin induces apoptosis in human bladder cancer TSGH 8301
cells through mitochondria-dependent signal pathways. Int J Oncol.
37:1243–1250. 2010.
|
|
14
|
Williams LA, Möller W, Merisor E, Kraus W
and Rösner H: In vitro anti-proliferation/cytotoxic activity
of cantharidin (Spanish fly) and related derivatives. West Indian
Med J. 52:10–13. 2003.
|
|
15
|
Wang CC, Wu CH, Hsieh KJ, Yen KY and Yang
LL: Cytotoxic effects of cantharidin on the growth of normal and
carcinoma cells. Toxicology. 147:77–87. 2000.
|
|
16
|
Zheng LH, Bao YL, Wu Y, Yu CL, Meng X and
Li YX: Cantharidin reverses multidrug resistance of human hepatoma
HepG2/ADM cells via down-regulation of P-glycoprotein expression.
Cancer Lett. 272:102–109. 2008.
|
|
17
|
Honkanen RE: Cantharidin, another natural
toxin that inhibits the activity of serine/threonine protein
phosphatases types 1 and 2A. FEBS Lett. 330:283–286. 1993.
|
|
18
|
Fang G, Yu H and Kirschner MW: Control of
mitotic transitions by the anaphase-promoting complex. Philos Trans
R Soc Lond B Biol Sci. 354:1583–1590. 1999.
|
|
19
|
Shi WT, Wei L, Xiang J, et al: Chinese
patients with gastric cancer need targeted adjuvant chemotherapy
schemes. Asian Pac J Cancer Prev. 13:5263–5272. 2012.
|
|
20
|
Liu B, Gao HC, Xu JW, Cao H, Fang XD, Gao
HM and Qiao SX: Apoptosis of colorectal cancer UTC116 cells induced
by cantharidinate. Asian Pac J Cancer Prev. 13:3705–3708. 2012.
|
|
21
|
Hartwell LH and Weinert TA: Checkpoints:
controls that ensure the order of cell cycle events. Science.
246:629–634. 1989.
|
|
22
|
King RW, Jackson PK and Kirschner MW:
Mitosis in transition. Cell. 79:563–571. 1994.
|
|
23
|
Jackman M, Lindon C, Nigg EA and Pines J:
Active cyclin B1-Cdk1 first appears on centrosomes in prophase. Nat
Cell Biol. 5:143–148. 2003.
|
|
24
|
Malumbres M and Barbacid M: To cycle or
not to cycle: a critical decision in cancer. Nat Rev Cancer.
1:222–231. 2001.
|
|
25
|
Pines J: Cyclins, CDKs and cancer. Semin
Cancer Biol. 6:63–72. 1995.
|
|
26
|
van den Heuvel S: Cell-cycle regulation.
WormBook. 21:1–16. 2005.
|
|
27
|
Stark GR and Taylor WR: Control of the
G2/M transition. Mol Biotechnol. 32:227–248. 2006.
|
|
28
|
Lee DH, Park KI, Park HS, et al:
Flavonoids isolated from Korea citrus aurantium L. induce G2/M
phase arrest and apoptosis in human gastric cancer AGS cells. Evid
Based Complement Alternat Med. 2012:5159012012.
|
|
29
|
Huan SK, Lee HH, Liu DZ, Wu CC and Wang
CC: Cantharidin-induced cytotoxicity and cyclooxygenase 2
expression in human bladder carcinoma cell line. Toxicology.
223:136–143. 2006.
|
|
30
|
Herr I and Debatin KM: Cellular stress
response and apoptosis in cancer therapy. Blood. 98:2603–2614.
2001.
|
|
31
|
Launay S, Hermine O, Fontenay M, Kroemer
G, Solary E and Garrido C: Vital functions for lethal caspases.
Oncogene. 24:5137–5148. 2005.
|
|
32
|
Chen YC, Shen SC, Lee WR, Hsu FL, Lin HY,
Ko CH and Tseng SW: Emodin induces apoptosis in human
promyeloleukemic HL-60 cells accompanied by activation of caspase 3
cascade but independent of reactive oxygen species production.
Biochem Pharmacol. 64:1713–1724. 2002.
|
|
33
|
Harris MH and Thompson CB: The role of the
Bcl-2 family in the regulation of outer mitochondrial membrane
permeability. Cell Death Differ. 7:1182–1191. 2000.
|
|
34
|
Sagawa M, Nakazato T, Uchida H, Ikeda Y
and Kizaki M: Cantharidin induces apoptosis of human multiple
myeloma cells via inhibition of the JAK/STAT pathway. Cancer Sci.
99:1820–1826. 2008.
|
